Signatur Biosciences

Signatur Biosciences is dedicated to democratizing access to precision diagnostics, initially focusing on breast cancer prognosis. Existing diagnostic tests that inform treatment decisions are often time-consuming and costly, requiring specialized infrastructure and centralized facilities. Signatur Biosciences aims to streamline this process by developing tests that can be readily performed in local hospital laboratories. This approach significantly reduces turnaround times from over three weeks to just a few days, while also substantially lowering the cost of testing, ultimately improving patient care and outcomes.